Brief: Biomerica Reports FDA Submission For Test to Detect H. pylori
26/04/2022 13:21
April 26 (Reuters) - Biomerica Inc BMRA.O :
* BIOMERICA ANNOUNCES FDA SUBMISSION FOR A TEST TO DETECT
HELICOBACTER PYLORI (H. PYLORI), A BACTERIA THAT INFECTS
APPROXIMATELY 35% OF THE US POPULATION
* BIOMERICA INC - ALSO PREPARING TO SUBMIT A CE MARK FILING,
WHICH
WILL ENABLE PRODUCT TO BE SOLD IN MOST EU COUNTRIES AND OTHER
REGIONS AROUND WORLD
Source text for Eikon: ID:nGNX1pZNwx
Further company coverage: BMRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biomerica
See all newsDiagnostics firm Biomerica's Q1 revenue drops on lower clinical lab orders
Brief: Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants
Brief: Biomerica Lands $1.75 Million CDMO Master Services Agreement For IVD Diagnostic Development
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales
Brief: Biomerica Q3 Net Income USD -1.31 Million